Status:

UNKNOWN

Myocardial Damage in COVID-19

Lead Sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions:

COVID-19

Cardiovascular Diseases

Eligibility:

All Genders

18+ years

Brief Summary

This study aims to investigate the clinical characteristics, the incidence of myocardial injury, and the influence of myocardial injury on the prognosis in COVID-19 patients. There is no additional ex...

Detailed Description

The epidemic of the COVID-19 has expanded from Wuhan through out China, and is being exported to a growing number of countries. Recently, investigators have revealed that acute myocardial injury is ex...

Eligibility Criteria

Inclusion

  • (1) Age ≥18 years. (2) Laboratory (RT-PCR) confirmed infection with SARS-CoV-2. (3) Lung involvement confirmed with chest imaging.

Exclusion

  • No cTnI test on admission

Key Trial Info

Start Date :

January 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 18 2020

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04312464

Start Date

January 1 2020

End Date

March 18 2020

Last Update

March 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430022